Ursolic acid

Generic Name
Ursolic acid
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C30H48O3
CAS Number
77-52-1
Unique Ingredient Identifier
P3M2575F3F
Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

First Posted Date
2023-03-20
Last Posted Date
2024-04-23
Lead Sponsor
University of Miami
Target Recruit Count
20
Registration Number
NCT05776862
Locations
🇺🇸

University of Miami - Miami Project to Cure Paralysis, Miami, Florida, United States

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

Early Phase 1
Completed
Conditions
Bioavailability of Phytonutrients
Interventions
Drug: Curcumin
Drug: Ursolic Acid
First Posted Date
2020-06-09
Last Posted Date
2021-05-05
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
18
Registration Number
NCT04421716
Locations
🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

Early Phase 1
Withdrawn
Conditions
Prostate Cancer
Interventions
Drug: Ursolic Acid
Drug: Curcumin
First Posted Date
2020-05-27
Last Posted Date
2021-09-16
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT04403568
Locations
🇺🇸

Mays Cancer Center, San Antonio, Texas, United States

A Study Of Ursolic Acid For Primary Sclerosing Cholangitis

Phase 1
Withdrawn
Conditions
Primary Sclerosing Cholangitis
Interventions
Drug: Ursolic acid
First Posted Date
2017-07-13
Last Posted Date
2017-07-25
Lead Sponsor
University of California, Davis
Registration Number
NCT03216876
Locations
🇺🇸

Univeristy of California Davis Medical Center, Sacramento, California, United States

Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome

Phase 2
Completed
Conditions
Metabolic Syndrome X
Interventions
Drug: Ursolic acid
Drug: Placebo
First Posted Date
2015-01-14
Last Posted Date
2020-10-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
24
Registration Number
NCT02337933
Locations
🇲🇽

Instituto de Terapéutica Experimental y Clínica, Guadalajara, Jalisco, Mexico

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy